Silexion Therapeutics Corp (SLXNW) Gross margin
Silexion Therapeutics Corp (SLXNW) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to SLXNWSource: SEC XBRL filings · For reference only · Not investment advice
More SLXNW financial trends
SLXNW RevenueSLXNW Net incomeSLXNW Net marginSLXNW Gross profitSLXNW Operating incomeSLXNW Operating marginSLXNW Operating cash flowSLXNW Free cash flowSLXNW Capital expendituresSLXNW Return on equitySLXNW Stock buybacksSLXNW Dividends paidSLXNW Total assetsSLXNW Total liabilitiesSLXNW Shareholders’ equitySLXNW overview →